i
A Comparison of U.S. Clinical Laboratory Chlamydia and Gonorrhea Testing Practices Prior to and Following the 2014 CDC Testing Recommendations
-
6 2021
-
Source: Sex Transm Dis. 48(6):e73-e76
[PDF-279.76 KB]
Details:
-
Alternative Title:Sex Transm Dis
-
Personal Author:
-
Description:Background:
Adherence to recommended laboratory testing practices is crucial for sexually transmitted infection (STI) prevention and control. The objective of this paper is to compare Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) testing practices of US clinical laboratories in 2013 prior to the updated 2014 CDC recommendations and in 2015 following the updated recommendations.
Methods:
A total of 236 clinical laboratories participated in surveys about their 2013 and 2015 CT and NG testing practices, including questions on specimen types collected and assays used.
Results:
There was an increase of 5 laboratories offering CT NAAT testing from 2013 to 2015 and an increase of 5 laboratories offering NG NAAT testing. There was a net increase of three laboratories accepting urine for CT and NG NAAT testing, the preferred specimen type for males. There was not a net increase in the total number of laboratories accepting vaginal swabs for CT NAAT testing (n=89 in 2013 and 2015), the preferred specimen type for females, but there was an increase of three laboratories accepting vaginal swabs for NG NAAT testing. The number of laboratories performing NG susceptibility testing decreased from 100 in 2013 to 89 in 2015 (X2 = 1.07, p > 0.10).
Conclusions:
There were no major changes in testing practices in the two year period from 2013 to 2015. However, there were some small shifts, including increases in the use of NAATs, acceptance of CDC preferred specimen types for CT/NG, and changes in usage of assays by manufacturer.
-
Subjects:
-
Source:
-
Pubmed ID:32956240
-
Pubmed Central ID:PMC7969476
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
